JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $5,000 | -64.3% | 4,882 | -18.5% | 0.00% | – |
Q3 2022 | $14,000 | -75.9% | 5,990 | -68.5% | 0.00% | – |
Q2 2022 | $58,000 | -40.2% | 18,990 | +32.8% | 0.00% | – |
Q1 2022 | $97,000 | -18.5% | 14,303 | 0.0% | 0.00% | – |
Q4 2021 | $119,000 | +138.0% | 14,303 | +101.8% | 0.00% | – |
Q4 2020 | $50,000 | -13.8% | 7,088 | 0.0% | 0.00% | – |
Q3 2020 | $58,000 | +18.4% | 7,088 | 0.0% | 0.00% | – |
Q2 2020 | $49,000 | +44.1% | 7,088 | 0.0% | 0.00% | – |
Q1 2020 | $34,000 | -8.1% | 7,088 | +68.8% | 0.00% | – |
Q4 2019 | $37,000 | +164.3% | 4,200 | 0.0% | 0.00% | – |
Q3 2019 | $14,000 | – | 4,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |